Veeva Systems: First Patient Completes Digital Consent with Veeva Clinical Network in Phase 2b Study
Milestone accelerates industry s move toward paperless, patient-centric trials Veeva Systems (NYSE: VEEV) today announced that Veeva eConsent, a MyVeeva for Patients application built on Veeva Clinical Network, had its first patient complete an electronic consent for an early phase clinical trial by Crofoot Research Center. Veeva eConsent is the first validated application for sites and patients that transforms the consent process from manual and paper-based to an end-to-end digital experience. Patients can review documents and protocols and provide consent via mobile phone, streamlining the experience for both patients and sites.
Maggie White, Nurse Practitioner and Sub Investigator for Infectious Disease Research at The Crofoot Research Center discusses the process of vaccine testing, availability, and safety.
Dr. Jill Weatherhead, Asst. Professor, Tropical Medicine, Baylor College of Medicine, and Dr. Thomas Hunt, Professor and Chair of the Department of Orthopedic Surgery at Baylor College of Medicine, share their experiences of being among the first to receive the vaccine in Houston
Then, Dr. Patricia Hayes, Texas Medical Director of Partners in Primary Care answers COVID vaccine questions and concerns from listeners.
Town Square with Ernie Manouse is a gathering space for the community to come together and discuss the day s most important and pressing issues.